TP53 and cancer: The cyclin-dependent kinase inhibitor CDKN1A (p21) acts as a well-known tumor suppressor in many types of cancers, because p21 is one of the most important target of p53 and functioned as cell-cycle checking point to inhibit cancer cell over proliferation (Abbas and Dutta, 2009).